[1]
ALRUFAIE, S.H. and JANABI, A.M. 2026. ERTUGLIFLOZIN MITIGATES LIVER DAMAGE DURING SEPSIS: EVIDENCE FROM A MURINE MODEL. International Journal of Applied Pharmaceutics. 18, 1 (Jan. 2026), 617–624. DOI:https://doi.org/10.22159/ijap.2026v18i1.56581.